U.S. Water Utilities Stock News

Brookfield Business Partners (NYSE:BBU) has drawn fresh attention after recent trading left the units around $35.02, with returns mixed across the past week, month, and past 3 months, yet sharply positive over the past year. See our latest analysis for Brookfield Business Partners. At the current share price of $35.02, Brookfield Business Partners has seen a relatively soft short term share price return but a strong 1 year total shareholder return of 61.09%, which suggests momentum has been...

ResMed Q2 2026 earnings in focus ResMed (RMD) has just posted its Q2 2026 earnings, with revenue of about US$1.4b and basic EPS of US$2.69 setting the tone for the latest quarter. The company reported revenue of US$1,282.1m in Q2 2025 and US$1,422.8m in Q2 2026, while basic EPS over the same quarters moved from US$2.35 to US$2.69. This gives investors a clearer view of both top line and per share performance. With trailing net profit margins at 27.5% and earnings growth already in focus, this...

When you see that almost half of the companies in the Energy Services industry in the United States have price-to-sales...

WF International (NASDAQ:WXM) has had a rough three months with its share price down 83%. However, stock prices are...

Key Insights Significantly high institutional ownership implies Prime Medicine's stock price is sensitive to their...

Investors who take an interest in Worthington Steel, Inc. ( NYSE:WS ) should definitely note that the Independent...

Anyone interested in EverCommerce Inc. ( NASDAQ:EVCM ) should probably be aware that the Founder, Eric Remer, recently...

You may think that with a price-to-sales (or "P/S") ratio of 0.3x Pop Culture Group Co., Ltd ( NASDAQ:CPOP ) is a stock...

With a median price-to-sales (or "P/S") ratio of close to 1.1x in the Chemicals industry in the United States, you...

GDS Holdings Limited ( NASDAQ:GDS ) shareholders have had their patience rewarded with a 28% share price jump in the...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Investors in Chain Bridge Bancorp, Inc. ( NYSE:CBNA ) had a good week, as its shares rose 5.8% to close at US$35.24...

Lazard (NYSE:LAZ) has appointed Tracy Farr as its new Chief Financial Officer. The leadership change is intended to support the firm's long term growth and operational efficiency plans. Farr brings extensive internal experience at Lazard to the CFO role. Lazard, traded on the NYSE under the ticker NYSE:LAZ, recently closed at $53.72. The stock has seen a 4.6% return over the past week and 10.6% over the past month, with a 62.1% return over five years. In that context, a CFO transition can...

With the business potentially at an important milestone, we thought we'd take a closer look at NEXGEL, Inc.'s...

Caterpillar (CAT) just turned in its FY 2025 scorecard with fourth quarter revenue of US$19.1b and basic EPS of US$5.15, alongside net income of US$2.4b. Over recent quarters, the company has seen revenue move from US$16.0b in Q3 2024 to US$17.6b in Q3 2025 and then US$19.1b in Q4 2025. Basic EPS shifted from US$5.09 to US$4.91 and then US$5.15 over the same stretch, setting up a results season where investors are weighing solid top line scale against a backdrop of compressed net margins and...

Central Securities (CET) has been in focus after reporting 9.3% year over year growth in net assets and higher net assets per share, alongside its stock touching an all time high of US$52.46. See our latest analysis for Central Securities. The latest share price of US$52.10 sits just below its recent all time high, and the 1 year total shareholder return of 15.44% and 5 year total shareholder return of 106.06% point to momentum that has built over time rather than fading quickly. If Central...

Readers hoping to buy Princeton Bancorp, Inc. ( NASDAQ:BPRN ) for its dividend will need to make their move shortly, as...

With a price-to-earnings (or "P/E") ratio of 38.8x Vitesse Energy, Inc. ( NYSE:VTS ) may be sending very bearish...

If you are wondering whether BeOne Medicines is attractively priced right now, the key question is how its current share price stacks up against its underlying fundamentals. The stock has returned 0.3% over the last 7 days, 12.0% over 30 days, 9.4% year to date, 51.3% over 1 year and 32.5% over 3 years, while the 5 year return stands at an 8.5% decline. These moves sit against a backdrop of ongoing interest in the pharmaceuticals and biotech space, where investors often react quickly to...

If you are wondering whether Advanced Micro Devices shares are priced for perfection or still offer value, especially after their strong run, this article walks through what the numbers say about the stock. The share price recently closed at US$236.73, with a 1 year return of 104.2% and a 3 year return of 175.0%, even after a 7 day return of an 8.8% decline and a 30 day return of 10.5%. Recent headlines around Advanced Micro Devices have focused on its position in high performance chips and...

Asana’s recent performance in focus Asana (ASAN) has been drawing attention after a weak share price stretch, with the stock showing negative returns over the past month, past 3 months, year to date, and over the past year. See our latest analysis for Asana. At a share price of $10.25, Asana’s recent 7 day share price return of a 7.99% decline and 30 day share price return of a 25.24% decline suggest fading momentum, which lines up with its 51.97% 1 year total shareholder return decline and...

If you are wondering whether Olema Pharmaceuticals is still priced attractively after its recent run, this article walks through the numbers in a clear, valuation focused way. The stock recently closed at US$25.72, with returns of 1.9% over 7 days, 2.9% over 30 days, 1.7% year to date and 320.9% over the past year, while the 3 year return sits at 465.3% and the 5 year return at a 45.7% decline. Recent attention on Olema has centered on its position in the pharmaceuticals and biotech space...

Key Insights Significant control over Cheetah Mobile by public companies implies that the general public has more power...

WisdomTree (WT) just posted its FY 2025 third quarter numbers, with total revenue of US$125.6 million and basic EPS of US$0.14, setting the tone with US$19.0 million in net income excluding extraordinary items. The company has seen quarterly revenue move from US$108.1 million in Q1 FY 2025 to US$112.6 million in Q2 and US$125.6 million in Q3. Basic EPS shifted from US$0.17 in Q1 and Q2 to US$0.14 in Q3, all against a trailing twelve month backdrop of US$457.0 million in revenue and EPS of...